295 related articles for article (PubMed ID: 29678698)
1. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
[TBL] [Abstract][Full Text] [Related]
2. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
[TBL] [Abstract][Full Text] [Related]
3. B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft.
Smucker JD; Bobst JA; Petersen EB; Nepola JV; Fredericks DC
Spine (Phila Pa 1976); 2008 May; 33(12):1324-9. PubMed ID: 18496344
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
5. Accelerating autograft maturation in instrumented posterolateral lumbar spinal fusions without donor site morbidity.
Rogozinski A; Rogozinski C; Cloud G
Orthopedics; 2009 Nov; 32(11):809. PubMed ID: 19902899
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
7. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion.
Sandhu HS; Toth JM; Diwan AD; Seim HB; Kanim LE; Kabo JM; Turner AS
Spine (Phila Pa 1976); 2002 Mar; 27(6):567-75. PubMed ID: 11884903
[TBL] [Abstract][Full Text] [Related]
8. Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits.
Sun TS; Guan K; Shi SS; Zhu B; Zheng YJ; Cui FZ; Zhang W; Liao SS
Chin J Traumatol; 2004 Feb; 7(1):18-24. PubMed ID: 14728813
[TBL] [Abstract][Full Text] [Related]
9. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
[TBL] [Abstract][Full Text] [Related]
10. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
12. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
[TBL] [Abstract][Full Text] [Related]
13. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
14. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel silicate substituted hydroxyapatite bone graft substitute in a rabbit posterolateral fusion model.
Fredericks DC; Petersen EB; Sahai N; Corley KG; DeVries N; Grosland NM; Smucker JD
Iowa Orthop J; 2013; 33():25-32. PubMed ID: 24027457
[TBL] [Abstract][Full Text] [Related]
16. Development of a New Zealand white rabbit model of spinal pseudarthrosis repair and evaluation of the potential role of OP-1 to overcome pseudarthrosis.
Grauer JN; Vaccaro AR; Kato M; Kwon BK; Beiner JM; Patel TC; Hilibrand AS; Chiba K; Albert TJ
Spine (Phila Pa 1976); 2004 Jul; 29(13):1405-12. PubMed ID: 15223930
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion.
Martin GJ; Boden SD; Titus L
Spine (Phila Pa 1976); 1999 Nov; 24(21):2188-93; discussion 2193-4. PubMed ID: 10562982
[TBL] [Abstract][Full Text] [Related]
19. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion.
Boden SD; Martin GJ; Morone M; Ugbo JL; Titus L; Hutton WC
Spine (Phila Pa 1976); 1999 Feb; 24(4):320-7. PubMed ID: 10065514
[TBL] [Abstract][Full Text] [Related]
20. Purified bovine BMP extract and collagen for spine arthrodesis: preclinical safety and efficacy.
Damien CJ; Grob D; Boden SD; Benedict JJ
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S50-8. PubMed ID: 12205421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
